$23.70
1.848.42%
Last update: Nov 6, 4:00 PM
Damora Therapeutics Inc
DMRANASDAQ
The average analyst price target for Damora Therapeutics is $48.57, 104.9% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $40 to $60. The latest change came on Nov 6, 2026, when Guggenheim lowered its price target on Damora Therapeutics from $60 to $59 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
